These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24722171)

  • 1. Testosterone and cardiovascular disease.
    Schooling CM
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):202-8. PubMed ID: 24722171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
    Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
    Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
    J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of androgens on lipids.
    Monroe AK; Dobs AS
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):132-9. PubMed ID: 23422242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heart risk due to testosterone?].
    Grätzel P
    MMW Fortschr Med; 2015 Apr; 157(6):27. PubMed ID: 26015192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Androgens and cardiovascular risk: A series of case report in the French and Canadian pharmacovigilance databases].
    Rochoy M; Thomas R; Béné J; Deleplanque D; Vantyghem MC; Gautier S; Deplanque D;
    Prog Urol; 2018 May; 28(6):315-321. PubMed ID: 29650456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews.
    Onasanya O; Iyer G; Lucas E; Lin D; Singh S; Alexander GC
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):943-956. PubMed ID: 27669646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Testosterone replacement therapy and cardiovascular risk].
    Corona G; Dicuio M; Rastrelli G; Sforza A; Maggi M
    G Ital Cardiol (Rome); 2017 Nov; 18(11):745-753. PubMed ID: 29105668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis.
    Alexander GC; Iyer G; Lucas E; Lin D; Singh S
    Am J Med; 2017 Mar; 130(3):293-305. PubMed ID: 27751897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian randomization: Its impact on cardiovascular disease.
    Kawashiri MA; Tada H; Nomura A; Yamagishi M
    J Cardiol; 2018 Oct; 72(4):307-313. PubMed ID: 29801689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editor's Comment--How Dangerous is Testosterone Supplementation?
    Jenkins LC; Mulhall JP
    Int Braz J Urol; 2015; 41(2):195-8. PubMed ID: 26005958
    [No Abstract]   [Full Text] [Related]  

  • 12. Testosterone use in women: how safe is it?
    Tan RS; Teoh SH
    Curr Drug Saf; 2013 Apr; 8(2):120-7. PubMed ID: 23713539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone therapy and cardiovascular risk.
    Walsh JP; Kitchens AC
    Trends Cardiovasc Med; 2015 Apr; 25(3):250-7. PubMed ID: 25467243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
    Jones TH; Kelly DM
    Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on heart disease risk associated with testosterone boosting medications.
    Corona G; Rastrelli G; Guaraldi F; Tortorici G; Reismann Y; Sforza A; Maggi M
    Expert Opin Drug Saf; 2019 Apr; 18(4):321-332. PubMed ID: 30998433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone for peri- and postmenopausal women.
    Somboonporn W; Davis S; Seif MW; Bell R
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004509. PubMed ID: 16235365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone therapy and prostate cancer--safety concerns are well founded.
    Klotz L
    Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone, aging and survival: biomarker or deficiency.
    Shores MM; Matsumoto AM
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):209-16. PubMed ID: 24722173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.